109 related articles for article (PubMed ID: 11002520)
1. [New treatments for germ cell tumors with poor prognosis].
Arance A; García del Muro X; Montes A; Germà Lluch JR
Arch Esp Urol; 2000; 53(6):517-21. PubMed ID: 11002520
[TBL] [Abstract][Full Text] [Related]
2. Long-term results of first-line sequential high-dose etoposide, ifosfamide, and cisplatin chemotherapy plus autologous stem cell support for patients with advanced metastatic germ cell cancer: an extended phase I/II study of the German Testicular Cancer Study Group.
Schmoll HJ; Kollmannsberger C; Metzner B; Hartmann JT; Schleucher N; Schöffski P; Schleicher J; Rick O; Beyer J; Hossfeld D; Kanz L; Berdel WE; Andreesen R; Bokemeyer C;
J Clin Oncol; 2003 Nov; 21(22):4083-91. PubMed ID: 14568987
[TBL] [Abstract][Full Text] [Related]
3. [Rescue chemotherapy in testicular germ cell tumors].
Salazar Soler R; Maroto Rey P; Solà Rocabert C; López López JJ
Arch Esp Urol; 2000; 53(6):554-64. PubMed ID: 11002524
[TBL] [Abstract][Full Text] [Related]
4. Cisplatin, etoposide and either bleomycin or ifosfamide in the treatment of disseminated germ cell tumors: final analysis of an intergroup trial.
Hinton S; Catalano PJ; Einhorn LH; Nichols CR; David Crawford E; Vogelzang N; Trump D; Loehrer PJ
Cancer; 2003 Apr; 97(8):1869-75. PubMed ID: 12673712
[TBL] [Abstract][Full Text] [Related]
5. Phase I/II study of sequential dose-intensified ifosfamide, cisplatin, and etoposide plus paclitaxel as induction chemotherapy for poor prognosis germ cell tumors by the German Testicular Cancer Study Group.
Hartmann JT; Gauler T; Metzner B; Gerl A; Casper J; Rick O; Horger M; Schleicher J; Derigs G; Mayer-Steinacker R; Beyer J; Kuczyk MA; Bokemeyer C;
J Clin Oncol; 2007 Dec; 25(36):5742-7. PubMed ID: 18089869
[TBL] [Abstract][Full Text] [Related]
6. First-line high-dose chemotherapy for patients with poor prognosis extragonadal germ cell tumors: the experience of the European Bone Marrow Transplantation (EBMT) Solid Tumors Working Party.
Rosti G; De Giorgi U; Wandt H; Lioure B; Leyvraz S; Kolbe K; Papiani G; Ballardini M; Kulekci A; Demirer T;
Bone Marrow Transplant; 2004 Dec; 34(12):1033-7. PubMed ID: 15516940
[TBL] [Abstract][Full Text] [Related]
7. Phase III randomized trial of conventional-dose chemotherapy with or without high-dose chemotherapy and autologous hematopoietic stem-cell rescue as first-line treatment for patients with poor-prognosis metastatic germ cell tumors.
Motzer RJ; Nichols CJ; Margolin KA; Bacik J; Richardson PG; Vogelzang NJ; Bajorin DF; Lara PN; Einhorn L; Mazumdar M; Bosl GJ
J Clin Oncol; 2007 Jan; 25(3):247-56. PubMed ID: 17235042
[TBL] [Abstract][Full Text] [Related]
8. Long-term results of first-line sequential high-dose carboplatin, etoposide and ifosfamide chemotherapy with peripheral blood stem cell support for patients with advanced testicular germ cell tumor.
Miki T; Mizutani Y; Akaza H; Ozono S; Tsukamoto T; Terachi T; Naito K; Nonomura N; Hara I; Yoshida O;
Int J Urol; 2007 Jan; 14(1):54-9. PubMed ID: 17199861
[TBL] [Abstract][Full Text] [Related]
9. [Is still there an indication for high-dose chemotherapy with hematopoietic stem-cell support in the treatment of germ-cell tumors?].
Fléchon A; Droz JP
Bull Cancer; 2001 Sep; 88(9):852-7. PubMed ID: 11604357
[TBL] [Abstract][Full Text] [Related]
10. Improved long term survival of patients with metastatic nonseminomatous testicular germ cell carcinoma in relation to prognostic classification systems during the cisplatin era.
Sonneveld DJ; Hoekstra HJ; van der Graaf WT; Sluiter WJ; Mulder NH; Willemse PH; Koops HS; Sleijfer DT
Cancer; 2001 Apr; 91(7):1304-15. PubMed ID: 11283931
[TBL] [Abstract][Full Text] [Related]
11. Chemotherapy in patients with metastatic or relapsed germ-cell tumours.
Rick O; Siegert W; Beyer J
Cancer Treat Rev; 2001 Oct; 27(5):283-8. PubMed ID: 11871864
[TBL] [Abstract][Full Text] [Related]
12. Sequential intermediate high-dose therapy with etoposide, ifosfamide and cisplatin for patients with germ cell tumors.
Mardiak J; Fuchsberger P; Lakota J; Sálek T; Sycová-Milá Z; Drahokoupilová M; Baláz M; Koza I
Neoplasma; 2000; 47(4):239-43. PubMed ID: 11043829
[TBL] [Abstract][Full Text] [Related]
13. [High-dose chemotherapy with transplantation of autologous stem cells in advanced germ-cell poor-risk testicular tumors].
May M; Georgieva G; Gunia S; Peter N; Steinhauer HB; Hoschke B
Urologiia; 2007; (2):58-63. PubMed ID: 17578200
[TBL] [Abstract][Full Text] [Related]
14. High dose chemotherapy and stem cell support in the treatment of germ cell cancer.
Margolin K
J Urol; 2003 Apr; 169(4):1229-33. PubMed ID: 12629333
[TBL] [Abstract][Full Text] [Related]
15. Risk factors in germ cell tumour patients with relapse or progressive disease after first-line chemotherapy: evaluation of a prognostic score for survival after high-dose chemotherapy.
Sammler C; Beyer J; Bokemeyer C; Hartmann JT; Rick O
Eur J Cancer; 2008 Jan; 44(2):237-43. PubMed ID: 18055194
[TBL] [Abstract][Full Text] [Related]
16. First-line chemotherapy of non-seminomatous germ cell tumors(NSGCTs).
Pliarchopoulou K; Pectasides D
Cancer Treat Rev; 2009 Nov; 35(7):563-9. PubMed ID: 19576697
[TBL] [Abstract][Full Text] [Related]
17. High-dose chemotherapy with autologous stem-cell support for germ cell tumors: a critical review.
Sobecks RM; Vogelzang NJ
Semin Oncol; 1999 Feb; 26(1):106-18. PubMed ID: 10073567
[TBL] [Abstract][Full Text] [Related]
18. Management of metastatic germ cell tumors.
Hussain SA; Ma YT; Cullen MH
Expert Rev Anticancer Ther; 2008 May; 8(5):771-84. PubMed ID: 18471049
[TBL] [Abstract][Full Text] [Related]
19. [Treatment of germ cell tumors at the threshold of the third millennium].
Géczi L; Biron P; Droz JP
Orv Hetil; 2001 Aug; 142(31):1673-9. PubMed ID: 11556261
[TBL] [Abstract][Full Text] [Related]
20. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
Hagemeister FB
Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
